Glycemic variability evaluated by HbA1c rather than fasting plasma glucose is associated with adverse cardiovascular

Lijuan Sheng1, Guifang Yang2,3,4, Xiangping Chai2,3,4

  • 1Clinical Nursing Teaching and Research Section, Second Xiangya Hospital, Central South University, Changsha, China.

Frontiers in Endocrinology
|February 29, 2024
PubMed

Insights

Increased hemoglobin A1c (HbA1c) variability, not fasting plasma glucose (FPG) variability, is linked to major adverse cardiovascular events (MACEs) in type 2 diabetes. Intensive glucose control may worsen this association.

Area of Science:

  • Cardiology
  • Endocrinology
  • Metabolic Diseases

Background:

  • Glycemic variability is linked to cardiovascular disease risk.
  • Few studies compare HbA1c and FPG variability concerning cardiovascular events in type 2 diabetes mellitus (T2DM).

Purpose of the Study:

  • To investigate the association between HbA1c and FPG variability and major adverse cardiovascular events (MACEs) in T2DM patients.
  • To explore the impact of glucose control strategies on this relationship.

Main Methods:

  • Post hoc analysis of the ACCORD study.
  • Cox proportional hazards models used to assess HbA1c/FPG variability and MACEs incidence.
  • Analysis included 9,547 T2DM patients with a median follow-up of 4.6 years.

Main Results:

  • Higher HbA1c variability quartiles showed a significant increase in MACEs risk (HR 1.37 in the fourth quartile).
  • FPG variability was not significantly associated with MACEs (P for trend=0.28).
  • A U-shaped relationship observed between glycemic variability and MACEs; intensive glucose control amplified MACEs risk with higher HbA1c variability (P for interaction <0.01).

Conclusions:

  • In T2DM, increased HbA1c variability, not FPG variability, is significantly associated with MACEs.
  • Glycemic variability exhibits a U-shaped relationship with MACEs.
  • Glucose control strategy influences the HbA1c variability-MACEs link, with intensive control posing higher risk.
Abstract

Related Concept Videos

Diabetes Mellitus: Type 2 and Gestational01:22

Diabetes Mellitus: Type 2 and Gestational

Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
2.4K
Hypoglycemia and Glucagon01:15

Hypoglycemia and Glucagon

Without prolonged fasting, healthy individuals maintain blood glucose levels above 3.5 mM due to a well-adapted neuroendocrine counterregulatory system that effectively prevents acute hypoglycemia, a potentially life-threatening condition. The primary clinical scenarios for hypoglycemia encompass diabetes treatment, inappropriate production of endogenous insulin or insulin-like substances by tumors, and the use of glucose-lowering agents in non-diabetic individuals. Notably, hypoglycemia in the...
260
Diabetes: Symptoms, Diagnosis, and Complications01:15

Diabetes: Symptoms, Diagnosis, and Complications

For most patients, experiencing several weeks of polyuria, polydipsia, fatigue, and significant weight loss may indicate the presence of diabetes. Furthermore, adults displaying the phenotypic appearance of type 2 diabetes (particularly those who are obese and not initially insulin-requiring), may have islet cell autoantibodies, suggesting autoimmune-mediated β cell destruction and a diagnosis of latent autoimmune diabetes of adults (LADA). The categorization of glucose homeostasis is...
534
Overview of Carbohydrate Metabolism01:19

Overview of Carbohydrate Metabolism

Carbohydrate metabolism is a fundamental biochemical process that ensures a constant supply of energy to living cells. The most important carbohydrate is glucose, which can be broken down via glycolysis to enter into the Krebs cycle and eventually lead to the production of ATP through oxidative phosphorylation.
Glucose transport into cells is facilitated by a family of transport proteins called GLUT (Glucose Transporters). GLUT4 is the primary glucose transporter for insulin-stimulated glucose...
1.0K
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
91
Variability: Analysis01:11

Variability: Analysis

Measures of variability are statistical metrics that reveal the dispersion pattern within a dataset. They are pivotal in biostatistics, providing insights into the heterogeneity within health and biological data. Variability signifies the degree to which data points diverge from one another, helping researchers understand the potential range of values and associated uncertainty within the data.
The range is a simple measure of variability, indicating the difference between the highest and...
143